American Journal of Physiology-Gastrointestinal and Liver Physiology · 2012 · 92 citations · 59 references
Life SciencesEndocrinologyNutritional SciencesMetabolic RegulationRodent MedicineSteroid BiochemistryHormonal Control Of MetabolismInsulin ResistanceLiver DiseaseMetabolic Liver DiseaseRodent EndocrinologyRodent NutritionGlucocorticoid Regulation Of MetabolismHepatic Insulin ResistanceHepatic Lipid AccumulationHepatic Lipid MetabolismHepatic Lipid StorageHepatic Metabolic RegulationHigh-fat Diet-induced Liver InjuryNonalcoholic Fatty Liver Disease-associated Insulin Resistance
Chronically elevated glucocorticoids (GCs) and a high-fat diet (HFD) independently induce insulin resistance, abdominal obesity, and nonalcoholic fatty liver disease (NAFLD). GCs have been linked to increased food intake, particularly energy-dense "comfort" foods. Thus we examined the synergistic actions of GCs and HFD on hepatic disease development in a new rodent model of chronically elevated GCs. Six-week-old male Sprague-Dawley rats received exogenous GCs, via subcutaneous implantation of four 100-mg corticosterone (Cort) pellets, to elevate basal GC levels for 16 days (n = 8-10 per group). Another subset of animals received wax pellets (placebo) to serve as controls. Animals from each group were randomly assigned to receive a 60% HFD or a standard high-carbohydrate (13% fat and 60% carbohydrate) diet. Cort + HFD resulted in central obesity, despite a relative weight loss, a 4-fold increase in hepatic lipid content, hepatic fibrosis, and a 2.8-fold increase in plasma alanine aminotransferase levels compared with placebo + chow controls. Hepatic injury developed independent of inflammation, as plasma haptoglobin levels were reduced with Cort treatment. Insulin resistance and hepatic steatosis occurred with Cort alone; these outcomes were further exacerbated by the HFD in the presence of elevated Cort. In addition to fatty liver, the Cort + HFD group also developed severe insulin resistance, hyperinsulinemia, hyperglycemia, and hypertriglyceridemia, which were not evident with HFD or Cort alone. Thus a HFD dramatically exacerbates the development of NAFLD and characteristics of the metabolic syndrome in conditions of chronically elevated Cort.
59
Kerry L. Donnelly, Coleman I. Smith, Sarah Jane Schwarzenberg et al. · Journal of Clinical Investigation · 2005 · 3.5K citations · Full text
Nonalcoholic Fatty Liver Disease
Giulio Marchesini, Mara Brizi, Giampaolo Bianchi et al. · Diabetes · 2001 · 2.6K citations · Full text
Medicine, Pathology, Hepatology +11
Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease
Varman T. Samuel, Zhen Xiang Liu, Xianqin Qu et al. · Journal of Biological Chemistry · 2004 · 1.3K citations · Full text